3D Systems (DDD) Q2 2024 earnings summary

Executive summary

• Q2 2024 revenue was $113.3 million, up 10.1% sequentially but down 11.7% year-over-year, mainly due to weaker printer sales, with services growth partially offsetting declines.

• Net loss for Q2 2024 was $27.3 million, nearly flat year-over-year; adjusted EBITDA was -$12.9 million, reflecting lower sales and higher audit-related costs.

• Gross profit margin improved to 41.6% in Q2 2024, up from 39.0% a year ago, driven by favorable mix and insourcing activities.

• The company expects continued sequential revenue growth in Q3 and Q4, projecting full-year 2024 revenues of $450–$460 million and near break-even adjusted EBITDA in Q4.

• Operating expenses were elevated due to one-time audit-related costs but are expected to normalize in Q4, with restructuring efforts yielding future savings.

Financial highlights

• First half 2024 revenues: $216.2 million, down 13% year-over-year, with Q2 revenue at $113.3 million.

• Healthcare revenues: $94.3 million (down 13.9%); industrial revenues: $121.8 million (down 12.9%) for H1 2024.

• Q2 2024 gross margin: 41.6% (Non-GAAP: 40.9%), up from 39.0% (Non-GAAP: 38.9%) year-over-year.

• Adjusted EBITDA: -$20.1 million (Q1), -$12.9 million (Q2); net loss for H1 2024 was $43.3 million.

• Cash and equivalents at June 30, 2024: $192.7 million, after $87 million spent on note repurchases.

Outlook and guidance

• Full-year 2024 revenue guidance: $450–$460 million, with sequential growth expected in Q3 and Q4.

• Non-GAAP gross margin projected at 40–42% for the year.

• Full-year OpEx projected at $248–$253 million, with Q4 OpEx below $60 million.

• Adjusted EBITDA expected to approach breakeven in Q4.

• Limited printer sales to a key dental customer expected for the remainder of 2024; materials sales to this customer to remain at higher volumes but lower prices.